Ahmed Hjazi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Urinary Tract Infection

Multiple Myeloma

Top Venues

Medical oncology (Northwood, London, England)

Medicina (Kaunas, Lithuania)

Phytotherapy research : PTR

Cell biochemistry and biophysics

This page only lists publications with an associated author ORCID identifier.

Publications

Dongmei Sun, Farag M A Altalbawy, Alexey Yumashev, Ahmed Hjazi, Soumya V Menon, Mandeep Kaur, Mahamedha Deorari, Alzahraa S Abdulwahid, Maha Noori Shakir, Baneen Chasib Gabal
Shedding Light on the Role of Exosomal PD-L1 (ExoPD-L1) in Cancer Progression: an Update. Cell biochemistry and biophysics (2024)
Abdulkarim S Binshaya, Omar Saad Alkahtani, Fahad M Aldakheel, Ahmed Hjazi, Hassan Hussain Almasoudi
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer. Medical oncology (Northwood, London, England) 41 (5) (2024)
Abdulkarim S Binshaya, Omar Saad Alkahtani, Fahad M Aldakheel, Ahmed Hjazi, Hassan Hussain Almasoudi
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer. Medical oncology (Northwood, London, England) 41 (5) (2024)
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Farag M A Altalbawy, Ahmed Hjazi, S Renuka Jyothi, Ashwani Kumar, Mamdouh Eldesoqui, M T Rasulova, Aashna Sinha, Ahmed Hussein Zwamel
Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy. Medical oncology (Northwood, London, England) 41 (7) (2024)
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Farag M A Altalbawy, Ahmed Hjazi, S Renuka Jyothi, Ashwani Kumar, Mamdouh Eldesoqui, M T Rasulova, Aashna Sinha, Ahmed Hussein Zwamel
Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy. Medical oncology (Northwood, London, England) 41 (7) (2024)
Abdulkarim S Binshaya, Omar Saad Alkahtani, Fahad M Aldakheel, Ahmed Hjazi, Hassan Hussain Almasoudi
Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer. Medical oncology (Northwood, London, England) 41 (5) (2024)
Neha Rana, Sandeep Kumar Singh, Najitha A Banu, Ahmed Hjazi, Emanuel Vamanu, Mahendra P Singh
The Ethnopharmacological Properties of Green-Engineered Metallic Nanoparticles against Metabolic Disorders. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Mohammed Alissa, Ahmed Hjazi, Ghadah S Abusalim, Ghfren S Aloraini, Suad A Alghamdi, Waleed Yousof Rizg, Khaled M Hosny, Jazia A Alblowi, Hanaa Alkharobi
Development and Optimization of a Novel Lozenge Containing a Metronidazole-Peppermint Oil-Tranexamic Acid Self-Nanoemulsified Delivery System to Be Used after Dental Extraction: In Vitro Evaluation and In Vivo Appraisal. Pharmaceutics 15 (9) (2023)
Neha Rana, Sandeep Kumar Singh, Najitha A Banu, Ahmed Hjazi, Emanuel Vamanu, Mahendra P Singh
The Ethnopharmacological Properties of Green-Engineered Metallic Nanoparticles against Metabolic Disorders. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Ahmed Hjazi
The effects of Capsicum annuum supplementation on lipid profiles in adults with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Phytotherapy research : PTR (2023)
Mahdi Shekari, Amir Hadi, Hamid Mahmood Abdullah Daabo, Zahra Haj Allahyari, Ahmed Hjazi, Nahid Rafie, Mohammad Heidari
Propolis as an adjunctive therapy for treatment of uncomplicated cystitis in women: A randomized double-blind placebo-controlled trial. Phytotherapy research : PTR (2023)
Neha Rana, Sandeep Kumar Singh, Najitha A Banu, Ahmed Hjazi, Emanuel Vamanu, Mahendra P Singh
The Ethnopharmacological Properties of Green-Engineered Metallic Nanoparticles against Metabolic Disorders. Medicina (Kaunas, Lithuania) 59 (6) (2023)